The immunopathology of multiple sclerosis: an overview (Q28295115)

Pathological abnormalities in the normal-appearing white matter in multiple sclerosis

Europe PubMed Central

title

The immunopathology of multiple sclerosis: an overview (English)

0 references

0 references

Hans Lassmann

1

0 references

Wolfgang Brück

series ordinal

2

0 references

Claudia F Lucchinetti

series ordinal

3

0 references

language of work or name

English

0 references

publication date

April 2007

0 references

published in

Brain Pathology

0 references

volume

17

0 references

issue

2

0 references

page(s)

210-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1750-3639.2007.00064.X

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1750-3639.2007.00064.X

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1750-3639.2007.00064.X

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1750-3639.2007.00064.X

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Axonal transection in the lesions of multiple sclerosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Lymphoid neogenesis in chronic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

ENCEPHALITIS PERIAXIALIS CONCENTRICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Subpial demyelination in the cerebral cortex of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Emerging monoclonal antibody therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Axonal damage in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Balo's concentric sclerosis: new observations on lesion development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Remyelination is extensive in a subset of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Immunopathology of secondary-progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

General mechanisms of axonal damage and its prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X

Primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2007.00064.X